| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 137 | 155 | 159 | 180 | 166 | 179 | 185 | 178 | 175 | 203 | 209 | 221 | 223 | 237 | 238 | 266 | 254 | 284 | 300 | 316 | 335 | 352 | 357 | 393 | 402 | 447 | 448 | 467 | 447 | 479 | 522 | 554 | 560 |
| Expenses | 103 | 116 | 125 | 139 | 125 | 132 | 135 | 131 | 125 | 143 | 146 | 159 | 157 | 173 | 179 | 202 | 202 | 210 | 214 | 224 | 234 | 253 | 249 | 282 | 281 | 305 | 310 | 321 | 298 | 329 | 389 | 424 | 400 |
| EBITDA | 35 | 39 | 35 | 41 | 41 | 47 | 50 | 47 | 50 | 60 | 63 | 63 | 66 | 64 | 59 | 64 | 51 | 74 | 86 | 92 | 101 | 99 | 108 | 112 | 121 | 142 | 138 | 146 | 149 | 150 | 132 | 130 | 160 |
| Operating Profit % | 23 % | 23 % | 20 % | 20 % | 23 % | 24 % | 25 % | 23 % | 27 % | 28 % | 28 % | 25 % | 26 % | 23 % | 22 % | 22 % | 19 % | 24 % | 25 % | 27 % | 27 % | 25 % | 27 % | 26 % | 27 % | 27 % | 27 % | 27 % | 26 % | 26 % | 21 % | 21 % | 24 % |
| Depreciation | 9 | 9 | 10 | 10 | 10 | 10 | 11 | 10 | 11 | 11 | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 15 | 16 | 16 | 16 | 16 | 20 | 21 | 21 | 21 | 23 | 25 | 29 | 38 | 36 |
| Interest | 4 | 7 | -1 | 2 | 3 | 2 | 5 | 8 | 3 | 3 | 5 | -2 | 3 | 0 | -1 | 2 | 1 | 0 | 5 | 2 | 3 | 2 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 6 | 6 | 7 |
| Profit Before Tax | 22 | 23 | 26 | 30 | 28 | 36 | 34 | 29 | 36 | 46 | 46 | 52 | 50 | 50 | 46 | 49 | 36 | 59 | 67 | 75 | 83 | 81 | 88 | 93 | 99 | 118 | 113 | 123 | 123 | 122 | 98 | 85 | 117 |
| Tax | 9 | 9 | 10 | 8 | 8 | 7 | 9 | 6 | 10 | 11 | 11 | 13 | 13 | 12 | 11 | 13 | 9 | 16 | 17 | 16 | 20 | 19 | 23 | 24 | 24 | 31 | 28 | 31 | 30 | 30 | 27 | 20 | 32 |
| Net Profit | 13 | 15 | 16 | 22 | 20 | 28 | 25 | 23 | 27 | 35 | 35 | 39 | 38 | 38 | 35 | 36 | 27 | 44 | 50 | 59 | 63 | 62 | 65 | 68 | 74 | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 |
| EPS in ₹ | 1.50 | 1.65 | 1.82 | 2.44 | 2.24 | 3.22 | 2.83 | 2.57 | 3.03 | 3.97 | 4.00 | 4.26 | 3.92 | 3.99 | 3.60 | 3.77 | 2.81 | 4.53 | 5.21 | 6.13 | 6.54 | 6.48 | 6.78 | 7.12 | 7.71 | 9.01 | 8.48 | 8.92 | 9.19 | 9.06 | 7.00 | 6.54 | 8.49 |
Poly Medicure
Poly Medicure
1,719.40
-50.20
(-2.84%)
Market Cap
17,427.75 Cr
PE Ratio
57.22
Volume
96,900.00
Day High - Low
1,783.80 - 1,710.00
52W High-Low
2,144.90 - 1,182.00
There are new updates from the company1 day ago
View
Key Fundamentals
Market Cap
17,427.75 Cr
EPS
31.79
PE Ratio
57.22
PB Ratio
5.76
Book Value
306.45
EBITDA
562.40
Dividend Yield
0.20 %
Industry
Healthcare Sector
Medical Equipment Return on Equity
10.18
Debt to Equity
0.09
Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Poly Medicure Limited will hold one-on-one virtual meetings with Wasatch Global and Bajaj Alternative Investment Ltd on August 20, 2026, as per SEBI LODR Regulation 30.
Poly Medicure Ltd has published a newspaper advertisement announcing its 31st Annual General Meeting scheduled for September 5, 2026. The notice, signed by Avinash Chandra, outlines the agenda for shareholder deliberations.
Poly Medicure Ltd reported consolidated revenue of ₹558.78 crore in Q1FY26, up 25.6% YoY. Consolidated net profit fell 8.4% to ₹85.27 crore, while standalone profit rose marginally.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,719.40 | #1 17,427.75 | #7 57.22 | #1 1,995.30 | #5 13.43 | #1 321 | #7 -8.38 | 48.88 | |
344.95 | 1,835.35 | 161.75 | 422.51 | 3.45 | 16 | -177.78 | 60.00 | |
549.75 | 1,282.47 | 21.43 | 341.74 | 5.93 | 56 | #1 314.63 | 58.58 | |
198.14 | 1,089.02 | 35.47 | 271.50 | 12.00 | 22 | 24.10 | 34.49 | |
400.55 | 712.76 | 23.40 | 292.67 | 56.84 | 30 | - | 47.63 | |
393.00 | 681.60 | 61.44 | 278.87 | 10.97 | 10 | 51.85 | 46.66 | |
146.82 | 652.63 | #1 13.38 | 410.77 | 22.29 | 36 | 168.85 | 41.59 | |
351.95 | 511.63 | 27.32 | 231.81 | #1 107.34 | 19 | - | 43.32 | |
407.00 | 488.50 | 21.49 | 71.81 | 7.02 | 21 | 27.27 | 60.56 | |
306.70 | 292.65 | 70.81 | 155.10 | 27.03 | 2 | 287.50 | 46.44 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
13.43 %
Net Income Growth
-5.29 %
Cash Flow Change
5.72 %
ROE
-16.83 %
ROCE
-19.02 %
EBITDA Margin (Avg.)
-8.59 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 364 | 387 | 457 | 565 | 654 | 767 | 1,224 | 1,377 | 1,577 | 1,859 | 3,193 | 3,919 |
| Fixed Assets | 166 | 182 | 207 | 265 | 306 | 363 | 426 | 488 | 635 | 867 | 1,084 | 1,694 |
| Current Assets | 160 | 171 | 205 | 255 | 302 | 318 | 704 | 783 | 807 | 842 | 1,922 | 1,942 |
| Capital Work in Progress | 10 | 14 | 20 | 18 | 19 | 25 | 21 | 43 | 78 | 76 | 101 | 99 |
| Investments | 0 | 0 | 3 | 17 | 8 | 25 | 354 | 346 | 126 | 167 | 1,076 | 755 |
| Other Assets | 189 | 191 | 227 | 264 | 321 | 354 | 422 | 499 | 738 | 749 | 931 | 1,371 |
| Total Equity & Liabilities | 364 | 387 | 457 | 565 | 654 | 767 | 1,224 | 1,377 | 1,577 | 1,859 | 3,193 | 3,919 |
| Current Liabilities | 113 | 109 | 114 | 123 | 154 | 197 | 171 | 227 | 293 | 351 | 370 | 576 |
| Non Current Liabilities | 55 | 50 | 72 | 104 | 119 | 135 | 87 | 63 | 42 | 37 | 57 | 194 |
| Total Equity | 196 | 229 | 272 | 338 | 381 | 435 | 966 | 1,088 | 1,242 | 1,470 | 2,766 | 3,149 |
| Reserve & Surplus | 174 | 207 | 227 | 294 | 337 | 391 | 918 | 1,040 | 1,194 | 1,422 | 2,715 | 3,056 |
| Share Capital | 22 | 22 | 44 | 44 | 44 | 44 | 48 | 48 | 48 | 48 | 51 | 51 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -2 | 1 | 0 | 3 | 1 | 1 | 0 | 3 | -1 | 5 | -3 | 43 |
| Investing Activities | -59 | -31 | -56 | -88 | -101 | -110 | -436 | -85 | -179 | -241 | -1,187 | -224 |
| Operating Activities | 63 | 63 | 56 | 75 | 107 | 131 | 119 | 124 | 191 | 266 | 233 | 246 |
| Financing Activities | -6 | -31 | -0 | 16 | -5 | -21 | 317 | -35 | -13 | -20 | 951 | 20 |
Share Holding
| % Holding | Feb 2021 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 44.88 % | 44.88 % | 44.77 % | 44.77 % | 44.76 % | 44.66 % | 53.34 % | 53.33 % | 53.33 % | 53.31 % | 53.31 % | 53.16 % | 53.16 % | 53.15 % | 66.03 % | 62.56 % | 62.56 % | 62.44 % | 62.44 % | 62.44 % | 62.42 % | 62.42 % | 62.42 % | 62.42 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 14.49 % | 0.00 % | 12.38 % | 9.91 % | 11.10 % | 11.87 % | 12.33 % | 11.46 % | 11.41 % | 9.77 % | 9.40 % | 5.91 % | 5.57 % |
| DIIs | 1.83 % | 1.92 % | 2.68 % | 2.73 % | 2.86 % | 3.18 % | 3.10 % | 3.20 % | 3.38 % | 3.68 % | 4.25 % | 5.15 % | 5.28 % | 7.22 % | 9.35 % | 12.48 % | 12.33 % | 11.66 % | 11.96 % | 11.72 % | 13.54 % | 13.84 % | 15.59 % | 16.08 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.24 % | 15.11 % | 14.24 % | 13.69 % | 13.24 % | 12.32 % | 11.93 % | 11.20 % | 11.18 % | 11.12 % | 11.10 % | 11.35 % | 11.38 % | 11.34 % | 11.37 % | 10.70 % | 10.14 % | 10.55 % | 11.08 % | 11.37 % | 11.25 % | 11.30 % | 12.61 % | 12.18 % |
| Others | 37.06 % | 38.10 % | 38.30 % | 38.81 % | 39.14 % | 39.84 % | 31.63 % | 32.27 % | 32.11 % | 31.90 % | 31.34 % | 15.85 % | 30.17 % | 15.92 % | 3.36 % | 3.16 % | 3.10 % | 3.03 % | 3.07 % | 3.07 % | 3.02 % | 3.04 % | 3.47 % | 3.76 % |
| No of Share Holders | 0 | 19,187 | 21,531 | 35,922 | 33,678 | 35,166 | 33,831 | 33,296 | 34,239 | 35,393 | 36,141 | 34,649 | 36,053 | 36,712 | 36,852 | 40,516 | 38,352 | 60,686 | 65,583 | 71,142 | 64,400 | 67,750 | 73,414 | 73,643 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 2.5 | 2 | 2 | 2 | 2.5 | 2.5 | 3 | 3 | 3.5 | 3.5 |
| Dividend Yield (%) | 1 | 0.91 | 0.86 | 0.24 | 0.26 | 0.27 | 0.19 | 0.13 | 0.29 | 0.2 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 05 Sept 2026 |  Annual General Meeting | NA | 05 Sept 2026 | 1,814.25 | 1,769.60 |
| 29 Aug 2026 |  Dividend | ₹ 3.50 /share | 28 Aug 2026 | 1,598.20 | 1,769.60 |
| 28 Mar 2017 |  Bonus | 1:1 | 24 Mar 2017 | 0.00 | 0.00 |
| 17 Sept 2021 | Dividend | ₹ 2.50 /share | 16 Sept 2021 | 1,133.15 | 955.00 |
| 19 Sept 2022 | Dividend | ₹ 2.50 /share | 16 Sept 2022 | 715.55 | 933.00 |
| 22 Sept 2023 | Dividend | ₹ 3.00 /share | 21 Sept 2023 | 977.25 | 1,413.65 |
| 20 Sept 2024 | Dividend | ₹ 3.00 /share | 19 Sept 2024 | 1,654.70 | 2,462.65 |
| 26 Sept 2024 | Annual General Meeting | NA | 26 Sept 2024 | 2,498.45 | 2,318.00 |
| 28 Oct 2024 |  Quarterly Result Announcement | NA | 28 Oct 2024 | 2,450.95 | 2,514.10 |
| 03 Feb 2025 | Quarterly Result Announcement | NA | 03 Feb 2025 | 2,445.25 | 2,433.90 |
| 06 May 2025 | Quarterly Result Announcement | NA | 06 May 2025 | 2,587.85 | 2,584.60 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 2,057.40 | 1,931.65 |
| 18 Sept 2025 | Dividend | ₹ 3.50 /share | 18 Sept 2025 | 2,584.60 | 1,996.60 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 2,067.00 | 1,981.35 |
| 08 Nov 2025 | Quarterly Result Announcement | NA | 08 Nov 2025 | 1,974.45 | 1,893.80 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 1,515.85 | 1,517.95 |
| 25 May 2026 | Quarterly Result Announcement | NA | 25 May 2026 | 1,598.75 | 1,598.20 |
| 07 Aug 2026 | Quarterly Result Announcement | NA | 07 Aug 2026 | 1,670.30 | 1,709.30 |
Announcements
Investors Call Scheduled To Be Held On 20 August 2026 Is Cancelled - Updates On Call
1 day ago
1 day agoIntimation For The Schedule Of Investors/Analysts Call/Meet.4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication6 days ago
6 days agoAnalyst Investor Meet Call Transcript7 days ago
7 days agoAnnual Report 2025-267 days ago
7 days agoRecord Date/Cut-Off Date For The Dividend Purpose7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Dividend Updates7 days ago
7 days agoBook Closure For The Purpose Of Record Date For The Purpose Of Dividend7 days ago
7 days agoIntimation Of Dispatch Of Letter To Shareholder Whose Email Address Are Not Registered With Company And Depository7 days ago
7 days agoBusiness Responsibility and Sustainability Reporting (BRSR)7 days ago
7 days ago31ST Annual General Meeting To Be Held On September 05Th 20267 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 10, 2026
Aug 10, 2026Statement Of Deviation & Variation For The Quarter Ended 30Th June 2026Aug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2026
Aug 07, 2026Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2026
Aug 07, 2026The Company Granted The 1476 ESOP Options To The Employees Under The ESOP Scheme 2020.Aug 07, 2026
Aug 07, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 07, 2026
Aug 07, 2026Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30Th June 2026Aug 07, 2026
Aug 07, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 07Th August 2026Aug 07, 2026
Aug 07, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 07Th August 2026Aug 07, 2026
Aug 07, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2026
Aug 05, 2026Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 07Th August 2026.Jul 31, 2026
Jul 31, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2026
Jul 14, 2026Update In Relation To The Proceedings Before The Honble Delhi High Court Regarding Stamp Duty MatterJul 08, 2026
Jul 08, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Credit RatingJun 26, 2026
Jun 26, 2026Poly Medicure Limited Has Informed The Exchange About The Re-Schedule Of Investor/Analyst MeetJun 23, 2026
Jun 23, 2026Intimation For The Schedule Of Investor/Analyst Call/MeetJun 22, 2026
Jun 22, 2026Intimation For The Schedule Of Investors/Analysts Call/MeetJun 18, 2026
Jun 18, 2026The Company Is In Receipt Of An Order Passed By Office Of Divisional Commissioner Government Of The NCT Of Delhi Revenue Department: Stamp & Registration Branch Through The Collector Of StampsJun 16, 2026
Jun 16, 2026Intimation Of Investor/Analyst MeetJun 12, 2026
Jun 12, 2026Investors/Analysts Meet ScheduleJun 10, 2026
Jun 10, 2026Intimation Of Analyst/Investor MeetJun 03, 2026
Jun 03, 2026Intimation For The Analyst/Investors MeetJun 02, 2026
Jun 02, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 29, 2026
May 29, 2026Investors Call Scheduled To Be Held On 27 May 2026 Is Cancelled - Updates On CallMay 26, 2026
May 26, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
May 26, 2026Declaration Of Unmodified Opinion On The Audited Financial Results(Standalone & Consolidated) For The Quarter And Year Ended For The 31St March 2026May 25, 2026
May 25, 2026Statement Of Deviation & Variation For The Quarter Ended On 31St March 2026May 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
May 25, 2026Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2026May 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
May 25, 2026Board Meeting Outcome for Poly Medicure Limited Has Submitted To The Exchange The Audited Financial Results(Standalone & Consolidated) For The Quarter And Year Ended March 31 2026.May 25, 2026
May 25, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 54.96
ATR(14)
Less Volatile 61.82
STOCH(9,6)
Neutral 45.94
STOCH RSI(14)
Neutral 20.37
MACD(12,26)
Bearish -2.61
ADX(14)
Weak Trend 24.14
UO(9)
Bearish 41.25
ROC(12)
Uptrend And Accelerating 2.62
WillR(14)
Neutral -54.90
About Poly Medicure
Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and...more
Website
Chairperson NameDevendra Raj Mehta
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
